Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,874 | -9,120 | -7,239 | -4,012 | -50,122 |
| Depreciation Amortization | 201 | 159 | 109 | 56 | 192 |
| Income taxes - deferred | -29,413 | N/A | N/A | N/A | -15,267 |
| Accounts receivable | 11 | 16 | 19 | -16 | N/A |
| Other Working Capital | -2,085 | -1,517 | -1,303 | 468 | 1,679 |
| Other Operating Activity | 91,505 | -1,892 | -794 | -538 | 53,201 |
| Operating Cash Flow | $-14,655 | $-12,354 | $-9,208 | $-4,042 | $-10,317 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51 | -49 | -36 | -18 | -339 |
| Other Investing Activity | 54 | 17 | -17 | 19 | 77 |
| Investing Cash Flow | $3 | $-32 | $-53 | $1 | $-262 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,016 | 9,016 | 5,007 | 5,007 | 15,885 |
| Financing Cash Flow | $9,016 | $9,016 | $5,007 | $5,007 | $15,885 |
| Beginning Cash Position | 9,276 | 9,276 | 9,276 | 9,276 | 3,970 |
| End Cash Position | 3,640 | 5,906 | 5,022 | 10,242 | 9,276 |
| Net Cash Flow | $-5,636 | $-3,370 | $-4,254 | $966 | $5,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,655 | -12,354 | -9,208 | -4,042 | -10,317 |
| Capital Expenditure | -51 | -49 | -36 | -18 | -339 |
| Free Cash Flow | -14,706 | -12,403 | -9,244 | -4,060 | -10,656 |